𝛼SK or SearchZylox Tonbridge (2190 HK): 2025 Good; International Presence, Product Launches Will Shape the Future
223 Views19 Mar 2026 08:30
Zylox-Tonbridge Medical Technology (2190 HK) sees strong revenue growth driven by neurovascular and peripheral vascular devices. International expansion alongside product launches will shape future.
What is covered in the Full Insight:
- Introduction and Overview of Zylox-Tonbridge
- 2025 Financial Performance
- Product Portfolio and Market Expansion
- R&D and Future Product Launches
- Outlook and Competitive Analysis
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Zylox Tonbridge (2190 HK): Domestic Holds, International Stellar in 1H26, Pipeline and Launches Key26 Aug 2026
- Zylox Tonbridge (2190 HK): 2025 Good; International Presence, Product Launches Will Shape the Future19 Mar 2026
- Zylox Tonbridge (2190 HK): Optimed Acquisition Is a Positive Step Forward Towards Future Growth21 Jan 2026
- Zylox Tonbridge Medical (2190 HK): No More Interventions Needed, Blockages Cleared for Growth05 Sep 2025
x